Detalhe da pesquisa
1.
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients.
J Antimicrob Chemother
; 76(7): 1893-1897, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855355
2.
Efficacy of intermittent short cycles of integrase inhibitor-based maintenance ART in virologically suppressed HIV patients.
J Antimicrob Chemother
; 75(5): 1321-1323, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977046
3.
Hepatitis A, hepatitis B and HPV vaccine needs and coverage in MSM initiating HIV PrEP in a sexual health clinic in Paris.
Sex Transm Infect
; 99(5): 361-362, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173130
4.
Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.
Clin Infect Dis
; 62(10): 1297-1303, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908792
5.
Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV Centre.
J Acquir Immune Defic Syndr
; 92(2): 144-152, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257296
6.
Clinical, epidemiological and therapeutic characteristics of Mycoplasma genitalium infection in a French STI center.
Infect Dis Now
; 52(1): 13-17, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547546
7.
INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels.
Open Forum Infect Dis
; 6(5): ofz177, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123690
8.
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients.
AIDS
; 17(2): 209-14, 2003 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-12545081
9.
Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
Clin Infect Dis
; 34(5): 662-7, 2002 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11810599
10.
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.
Antivir Ther
; 8(6): 603-9, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14760894
11.
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy.
Antivir Ther
; 17(8): 1601-4, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22941896
12.
Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir.
Antimicrob Agents Chemother
; 52(2): 491-6, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18039922
13.
Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.
Antimicrob Agents Chemother
; 52(4): 1542-4, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18250187
14.
Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
J Infect
; 54(4): 367-74, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16875739
15.
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Antimicrob Agents Chemother
; 48(12): 4687-92, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15561845
16.
Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.
J Acquir Immune Defic Syndr
; 36(3): 876-8, 2004 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15213573